Nanopath: Funding, Investors & Team (Nov 2026)
Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality molecular testing.
Nanopath has raised $39.0M across 3 funding rounds on record, the most recent a Series B of $25.0M announced in Nov 2026.
That round is above the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nanopath Company Profile and Key Stats
Latest funding round on record: Nov 2026.
Nanopath Funding Rounds
Nanopath raised $10.0M in a Series A announced in Aug 2022.
1.8 years later, an undisclosed round of $4.0M was announced in May 2024.
2.5 years later, a Series B of $25.0M was announced in Nov 2026.
Nanopath Investors
13 investors are recorded in total; the 5 named above are those the record identifies.
Nanopath Founders and Leadership Team
Contact details for the Nanopath team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Nanopath Funding Compared to Other Biotechnology Startups
Nanopath's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nanopath in Biotechnology and Cambridge
Companies Similar to Nanopath
Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…
Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.
Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…
Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Nanopath Funding FAQs
What does Nanopath do?
Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality molecular testing.
How much funding has Nanopath raised?
Nanopath has raised $39.0M across 3 rounds on record. The most recent is a Series B of $25.0M announced in Nov 2026.
When did Nanopath last raise funding?
Nanopath's most recent funding round on record is a Series B of $25.0M, announced in Nov 2026.
Who has invested in Nanopath?
Investors on record for Nanopath include Alumni Ventures, Norwest, SV Health Investors, National Science Foundation, National Institutes of Health. FundedIQ records 13 investors in total.
Who founded Nanopath?
FundedIQ lists Alison Burklund (Co-Founder & Co-CEO), Amogha Tadimety (Founder) at Nanopath.
Where is Nanopath headquartered?
Nanopath is based in Cambridge, Massachusetts, United States.
How many employees does Nanopath have?
Nanopath is in the 11-50 employee band.
When was Nanopath founded?
Nanopath was founded in 2019.
How does Nanopath's funding compare to other Biotechnology startups?
Nanopath's latest round of $25.0M is above the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's Nanopath Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nanopath is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.